Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/2005
12/29/2005WO2005123050A2 Five-membered heterocycles useful as serine protease inhibitors
12/29/2005WO2005122699A2 An improved process for the preparation of n-substituted hetero cyclic derivatives
12/29/2005WO2005115384A3 Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation
12/29/2005WO2005086656A3 Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
12/29/2005WO2005012294A8 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
12/29/2005WO2005007625A3 Heterocyclic amides with anti-tuberculosis activity
12/29/2005US20050288358 In which the amino is substituted by arylmethyl- or heteroarylmethyl- group, e.g., 2-Methoxybenzyl)-(2-phenylpyrrolidin-3-yl)-amine and 5-{[2-(3-Chloro-phenyl)-pyrrolidin-3-ylamino]-methyl}-6-methoxy-3-methyl-1,1a,3,7b-tetrahydro-3-aza-cyclopropa[a]naphalen-2-one; neurokinin 1 (Substance P) inhititors
12/29/2005US20050288353 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds
12/29/2005US20050288347 Certain triazole-based compounds, compositions, and uses thereof
12/29/2005US20050288335 Triamide-substituted heterobicyclic compounds
12/29/2005US20050288321 Alzheimer's disease ; 3-(2,3-dihydro-5,6-difluorobenzofur-7-yl)-4-[1-(piperidin-4-yl)-1H-indol-3-yl]pyrrole-2,5-dione; stimulating bone deposition
12/29/2005US20050288297 {4-[6-methoxy-7-(3-piperidylpropoxy)quinazolin-4-yl]piperazinyl}-N-[4-(methylethoxy)phenyl]carboxamide; inhibits phosphorylation of platelet-derived growth factor receptor to hinder abnormal cell growth/wandering; cancer; arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis
12/29/2005US20050288287 Chiral cis-imidazolines
12/29/2005US20050288286 Anti-inflammatory medicaments
12/29/2005US20050288282 Anticancer agents; antiproliferative agents
12/29/2005US20050288278 HIV replication inhibiting pyrimidines
12/29/2005US20050288271 Arylsulfonamides and uses related thereto
12/29/2005US20050288233 3-Azabicyclo[3.1.0]hexane derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus; AIDS
12/29/2005DE102004028862A1 3-Aminoindazole 3 aminoindazoles
12/29/2005DE102004027358A1 Pyrimidinverbindungen und ihre Verwendung Pyrimidine compounds and their use
12/29/2005CA2570472A1 Five-membered heterocycles useful as serine protease inhibitors
12/29/2005CA2570264A1 3-aminoindazoles
12/29/2005CA2569598A1 Novel cis-imidazolines
12/29/2005CA2568756A1 Substituted quinazolones as anti-cancer agents
12/28/2005EP1609790A2 Benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
12/28/2005EP1608646A1 Method for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2-(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate products
12/28/2005EP1608645A1 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses
12/28/2005EP1608641A1 A process for the synthesis of losartan potassium
12/28/2005EP1608632A1 Quinazolines useful as modulators of ion channels
12/28/2005EP1608622A2 Biaryl substituted 6-membered heterocyles as sodium channel blockers
12/28/2005EP1608375A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk
12/28/2005EP1608374A1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
12/28/2005EP1608317A2 Dipeptidyl peptidase inhibitors
12/28/2005EP1497240A4 Non-heating clay composites for building materials
12/28/2005EP1382604B1 Quinoline derivative having azolyl group and quinazoline derivative
12/28/2005EP1326643B1 Inhibition of emetic effect of metformin with 5-ht3 receptor antagonists
12/28/2005EP1303641B1 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
12/28/2005EP1224183B1 Heterocyclic sodium/proton exchange inhibitors and method
12/28/2005EP1223170B1 Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof
12/28/2005EP1173433B1 Cyanopyrroles as progesterone receptor agonists
12/28/2005EP1129089B1 Spiro-indolines as y5 receptor antagonists
12/28/2005EP0945445B9 1,5-benzodiazepine derivatives
12/28/2005CN1714084A Pyrimidine-2,4,6-trione metalloproteinase inhibitors
12/28/2005CN1714083A Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases
12/28/2005CN1714082A Process for preparation of imidazolyl compounds
12/28/2005CN1714078A Indoles useful in the treatment of androgen-receptor related diseases
12/28/2005CN1714077A 2-,3-4- or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy.
12/28/2005CN1713909A Aminoindazole derivatives and use thereof as kinase inhibitors
12/28/2005CN1713908A Aminoalkoxyindoles as 5-HT6-receptor ligands for the treatment of CNA-disorders
12/28/2005CN1234026C Electric filter for electronic display
12/27/2005US6979738 Quadruplex stabilizer
12/27/2005US6979696 Method for detecting a gram-negative bacterial autoinducer molecule
12/27/2005US6979693 Pyrazole derivatives-p38 MAP kinase inhibitors
12/27/2005US6979692 Triamide-substituted heterobicyclic compounds
12/27/2005US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/27/2005US6979684 useful as antitumor or anticancer agents
12/27/2005CA2356325C Topical compositions comprising protected functional thiols
12/22/2005WO2005121131A1 Dpp-iv inhibitors
12/22/2005WO2005121130A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005WO2005121128A1 5,6-diphenyl-1,2,4-triazinic dimeric derivatives and the use thereof in the form of sun-protective agents
12/22/2005WO2005121127A1 Squarylium compound, photoelectric conversion material using same, photoelectric converter and photoelectrochemical cell
12/22/2005WO2005121123A1 Compounds as cor5 antagonists
12/22/2005WO2005121121A2 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/22/2005WO2005121100A1 Melanocortin-4 receptor binding compounds and methods of use thereof
12/22/2005WO2005121085A1 Aza-bicyclo`3.1.0!hex-1-yl derivatives active as nk1 antagonists
12/22/2005WO2005121081A1 Method for producing acetamidopyrrolidine derivative and intermediate compound thereof
12/22/2005WO2005121080A1 Histamine h3 receptor agents, preparation and therapeutic uses
12/22/2005WO2005097778A8 Tetrahydrobenzazepines as histamine h3 receptor ligands
12/22/2005WO2005076854A3 Pyrimidinone compounds useful as kinase inhibitors
12/22/2005WO2004106296A3 Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators
12/22/2005WO2004082621A3 Novel ppar agonists, pharmaceutical compositions and uses thereof
12/22/2005US20050282907 Benzothiazole or benzothiazine derivative of dipyrido(2,3;b:2',3'-e) diazepin-6-one; viricide against human t-cell leukemia/lymphoma virus
12/22/2005US20050282864 Indole derivatives as H3 inverse agonists
12/22/2005US20050282861 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis
12/22/2005US20050282858 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/22/2005US20050282825 Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase
12/22/2005US20050282820 To a suspension of 2-(4-t-butylphenyl)-4-piperazin-1-yl-1H-benzimidazole and potassium carbonate in acetone was added 6-bromomethylquinoxaline to produce 2-(4-tert-butylphenyl)4-{[4-(6-quinoxalyl)methyl]piperazin-1-yl}benzimidazole Dihydrochloride Dihydrate
12/22/2005US20050282816 Pyrazinylmethyl lactam derivatives
12/22/2005US20050282814 Vasculostatic agents and methods of use thereof
12/22/2005US20050282812 Inhibitors of cholesteryl ester transfer protein
12/22/2005US20050282810 Oxindole derivatives
12/22/2005US20050282809 Heteroaryl-hydrazone compounds
12/22/2005US20050282805 Five-membered heterocycles useful as serine protease inhibitors
12/22/2005US20050282803 CIS-imidazolines
12/22/2005CA2570179A1 Method for producing acetamidopyrrolidine derivative and intermediate compound thereof
12/22/2005CA2569534A1 Dpp-iv inhibitors
12/22/2005CA2569111A1 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005CA2568451A1 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/22/2005CA2567513A1 Histamine h3 receptor agents, preparation and therapeutic uses
12/22/2005CA2567342A1 Aza-bicyclo[3.1.0]hex-1-yl derivatives active as nk1 antagonists
12/22/2005CA2566951A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
12/22/2005CA2529445A1 Melanocortin-4 receptor binding compounds and methods of use thereof
12/21/2005EP1606290A1 Weak base salts
12/21/2005EP1606286A2 Benodiazepine spirohydantoin cgrp receptor antagonists
12/21/2005EP1606284A1 Compositions useful as protein kinase inhibitors
12/21/2005EP1606283A2 P38 inhibitors and methods of use thereof
12/21/2005EP1606280A2 Tetrahydropyranyl cyclopentyl heterocylic amide modulators of chemokine receptor activity
12/21/2005EP1606268A1 Heterocyclic kinase inhibitors
12/21/2005EP1606266A2 Chemical compounds
12/21/2005EP1606265A1 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
1 ... 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 ... 626